Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0020440 (
hypercapnia
)
7,939
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Activation of the
platelet-activating factor receptor
(
PAFR
) regulates neural transmission. A
PAFR
blocker reduced the peak hypoxic (pHVR) but not hypercapnic ventilatory (HCVR) responses in rats [Am. J. Physiol. 275 (1998) R604]. To further examine the role of
PAFR
in respiratory control, genotype-verified
PAFR
-/- and
PAFR
+/+ adult male mice underwent hypoxic and hypercapnic challenges. HCVR was similar in the two groups (p-NS). However, pHVR was significantly reduced in
PAFR
-/- mice (38 +/- 13% baseline [S.D.]) compared to
PAFR
+/+ mice (78 +/- 16% baseline; P < 0.001, ANOVA), with reduced tidal volume recruitments during pHVR. In addition, hypoxic ventilatory depression was attenuated in
PAFR
-/- mice (P < 0.01), and was primarily due to attenuation of the time-dependent decreases in oxygen consumption during sustained hypoxia (P < 0.01). Thus,
PAFR
expression/function modulates components of the acute ventilatory and metabolic adaptations to hypoxia but not to
hypercapnia
. Imbalances in
PAFR
activity may lead to maladaptive regulation of the tightly controlled metabolic-ventilatory relationships during hypoxia.
...
PMID:Platelet-activating factor receptor and respiratory and metabolic responses to hypoxia and hypercapnia. 1523 72